Cargando…

Characterizing Prostiva(TM) RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRI

Transurethral needle ablation (TUNA) is an accepted and effective therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). Prostiva(TM) (Medtronic, Shoreview, MN) is the newest-generation device, which includes a new needle design and radio frequenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huidobro, Christian, Larson, Benjamin, Mynderse, Samuel, Myers, James J., Busel, David, Acevedo, Cristian, Larson, Thayne R., Mynderse, Lance A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823118/ https://www.ncbi.nlm.nih.gov/pubmed/19151893 http://dx.doi.org/10.1100/tsw.2009.4

Ejemplares similares

Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm(®) system: evaluation of acute ablative capabilities in the human prostate
por: Dixon, Christopher M, et al.
Publicado: (2015)

Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia
por: Dixon, Christopher M, et al.
Publicado: (2016)

Intraprostatic Injection of Alcohol Gel for the Treatment of Benign Prostatic Hyperplasia: Preliminary Clinical Results
por: Larson, Benjamin T., et al.
Publicado: (2006)

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

BPH and prostate cancer risk
por: Miah, Saiful, et al.
Publicado: (2014)

Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression
por: Jethwa, Krishan R., et al.
Publicado: (2016)

Patient Satisfaction of Telemedicine Visits in an Advanced Prostate Cancer Clinic During the COVID-19 Pandemic
por: Ahmed, Mohamed E., et al.
Publicado: (2021)

Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus ‘X’
por: Ahmed, Kamran A, et al.
Publicado: (2014)

Impact of measurement method on interobserver variability of apparent diffusion coefficient of lesions in prostate MRI
por: Takahashi, Hiroaki, et al.
Publicado: (2022)

Inflammasomes are important mediators of prostatic inflammation associated with BPH
por: Kashyap, Mahendra, et al.
Publicado: (2015)

Development of Interpretable Predictive Models for BPH and Prostate Cancer
por: Bermejo, Pablo, et al.
Publicado: (2015)

Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
por: Sciacqua, L. V., et al.
Publicado: (2023)

Management of BPH then 2000 and now 2016 – From BPH to BPO
por: Braeckman, Johan, et al.
Publicado: (2017)

Noninvasive Evaluation of Bladder Wall Mechanical Properties as a Function of Filling Volume: Potential Application in Bladder Compliance Assessment
por: Nenadic, Ivan, et al.
Publicado: (2016)

Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events
por: Ko, Young Hwii, et al.
Publicado: (2010)

Molecular Breeding of Rice Restorer Lines and Hybrids for Brown Planthopper (BPH) Resistance Using the Bph14 and Bph15 Genes
por: Wang, Hongbo, et al.
Publicado: (2016)

BPH management today
por: Mangera, Altaf, et al.
Publicado: (2014)

Assessment of BPH/BOO
por: Mangera, Altaf, et al.
Publicado: (2014)

Marker assisted pyramiding of Bph6 and Bph9 into elite restorer line 93–11 and development of functional marker for Bph9
por: Wang, Yang, et al.
Publicado: (2017)

The Role of TURP in the Detection of Prostate Cancer in BPH Patients with Previously Negative Prostate Biopsy
por: Kim, Dae Keun, et al.
Publicado: (2010)

Androgen Regulated Genes in Human Prostate Xenografts in Mice: Relation to BPH and Prostate Cancer
por: Love, Harold D., et al.
Publicado: (2009)

Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH
por: Saito, Motoaki, et al.
Publicado: (2014)

Bladder stone secondary to prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH)
por: Kang, JiHun
Publicado: (2021)

Correlation of ultrasound bladder vibrometry assessment of bladder compliance with urodynamic study results
por: Bayat, Mahdi, et al.
Publicado: (2017)

Recent advances in prostate cancer and BPH : the proceedings of the IV Congress on Progress and Controversies in Oncological Urology (PACIOU IV), held in Rotterdam, the Netherlands, April 1996 /
Publicado: (1997)

RF and microwave circuit design for wireless communications
por: Larson, Lawrence E
Publicado: (1997)

Management of the complications of BPH/BOO
por: Speakman, Mark J., et al.
Publicado: (2014)

Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)
por: Cambio, Angelo J, et al.
Publicado: (2007)

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?
por: Foo, Keong Tatt
Publicado: (2019)

Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil
por: Park, Hyun Jun, et al.
Publicado: (2013)

MRI spot sign: Gadolinium contrast extravasation in an expanding intracerebral hematoma on MRI
por: Allam, Talha, et al.
Publicado: (2019)

Acoustoelasticity Analysis of Transient Waves for Non-Invasive In Vivo Assessment of Urinary Bladder
por: Bayat, Mahdi, et al.
Publicado: (2019)

Long-term survival of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH.
por: Brawn, P. N., et al.
Publicado: (1994)

The Prostate Cancer Patient Had Higher C-Reactive Protein Than BPH Patient
por: Kim, Youngjun, et al.
Publicado: (2013)

L.I.F.T. study: Prostatic urethral lift for the treatment of LUTS associated with BPH
por: Gupta, Saurabh
Publicado: (2014)

How Readable Is BPH Treatment Information on the Internet? Assessing Barriers to Literacy in Prostate Health
por: Koo, Kevin, et al.
Publicado: (2016)

Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
por: Kucukdurmaz, Faruk, et al.
Publicado: (2017)

Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract
por: Asare, George Awuku, et al.
Publicado: (2015)

Non-Hormonal treatment of BPH/BOO
por: Osman, Nadir I., et al.
Publicado: (2014)

BPH treatment: laser for everyone | Opinion: NO
por: Almeida, Fernando G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fprr6sva0ausacdha0adl9p1v0